Cargando…

Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex

There are no wholly successful chemotherapeutic strategies against Burkholderia cepacia complex (BCC) colonization in cystic fibrosis (CF). We assessed the impact of cysteamine (Lynovex) in combination with standard-of-care CF antibiotics in vitro against BCC CF isolates by the concentration at whic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fraser-Pitt, Douglas, Mercer, Derry, Lovie, Emma, Robertson, Jennifer, O'Neil, Deborah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2016
Materias:	Experimental Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038277/ https://www.ncbi.nlm.nih.gov/pubmed/27503654 http://dx.doi.org/10.1128/AAC.01198-16

Ejemplares similares

Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis
por: Charrier, Cedric, et al.
Publicado: (2014)

Cysteamine as a Future Intervention in Cystic Fibrosis Against Current and Emerging Pathogens: A Patient-based ex vivo Study Confirming its Antimicrobial and Mucoactive Potential in Sputum
por: Devereux, Graham, et al.
Publicado: (2015)

Examining the activity of cefepime-taniborbactam against Burkholderia cepacia complex and Burkholderia gladioli isolated from cystic fibrosis patients in the United States
por: Mojica, Maria F., et al.
Publicado: (2023)

Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial
por: Devereux, Graham, et al.
Publicado: (2020)

Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada
por: Speert, David P., et al.
Publicado: (2002)

An Open-Label Investigation of the Pharmacokinetics and Tolerability of Oral Cysteamine in Adults with Cystic Fibrosis
por: Devereux, Graham, et al.
Publicado: (2016)

Burkholderia cepacia complex in Indian cystic fibrosis patients
por: Gautam, Vikas, et al.
Publicado: (2012)

Burkholderia cepacia complex: clinical course in cystic fibrosis patients
por: Folescu, Tania Wrobel, et al.
Publicado: (2015)

Preliminary Characterization of NP339, a Novel Polyarginine Peptide with Broad Antifungal Activity
por: Duncan, Vanessa, et al.
Publicado: (2021)

Cysteamine, an Endogenous Aminothiol, and Cystamine, the Disulfide Product of Oxidation, Increase Pseudomonas aeruginosa Sensitivity to Reactive Oxygen and Nitrogen Species and Potentiate Therapeutic Antibiotics against Bacterial Infection
por: Fraser-Pitt, Douglas J., et al.
Publicado: (2018)

Can Early Burkholderia cepacia Complex Infection in Cystic Fibrosis be Eradicated with Antibiotic Therapy?
por: Horsley, Alex, et al.
Publicado: (2011)

Polyphasic characterisation of Burkholderia cepacia complex species isolated from children with cystic fibrosis
por: Vicenzi, Fernando José, et al.
Publicado: (2016)

Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients
por: Garcia, Bryan A., et al.
Publicado: (2018)

A Case Report of Cystic Fibrosis Complicated by Burkholderia Cepacia and Cutaneous Vasculitis
por: Klimko, Artsiom, et al.
Publicado: (2020)

Burkholderia cepacia infection in a non-cystic fibrosis patient: an arcane presentation
por: Ibrahim, Sufyan, et al.
Publicado: (2021)

Evaluation of Three Culture Media for Isolation of Burkholderia cepacia Complex from Respiratory Samples of Patients with Cystic Fibrosis
por: Marrs, Emma C. L., et al.
Publicado: (2021)

Cysteamine Inhibits Glycine Utilisation and Disrupts Virulence in Pseudomonas aeruginosa
por: Fraser-Pitt, Douglas J., et al.
Publicado: (2021)

Cystic fibrosis – a multiorgan protein misfolding disease
por: Fraser-Pitt, Douglas, et al.
Publicado: (2015)

Burkholderia cepacia complex and limited cutaneous vasculitis in patients with cystic fibrosis: a case series
por: Kayria, Muttardi, et al.
Publicado: (2017)

Draft Genome Sequences of Burkholderia contaminans, a Burkholderia cepacia Complex Species That Is Increasingly Recovered from Cystic Fibrosis Patients
por: Bloodworth, Ruhi A. M., et al.
Publicado: (2015)

Improved Methods for Assessing Therapeutic Potential of Antifungal Agents against Dermatophytes and Their Application in the Development of NP213, a Novel Onychomycosis Therapy Candidate
por: Mercer, Derry K., et al.
Publicado: (2019)

Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis
por: Kitt, H., et al.
Publicado: (2016)

Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem
por: Narayanaswamy, Vidya P., et al.
Publicado: (2017)

Eradication of Burkholderia cepacia complex in cystic fibrosis patients with inhalation of amiloride and tobramycin combined with oral cotrimoxazole
por: Akkerman-Nijland, Anne M., et al.
Publicado: (2023)

NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus
por: Mercer, Derry K., et al.
Publicado: (2017)

Burkholderia cepacia infection in children without cystic fibrosis: a clinical analysis of 50 cases
por: Shi, Huixuan, et al.
Publicado: (2023)

In Vitro Activity of a Novel Glycopolymer against Biofilms of Burkholderia cepacia Complex Cystic Fibrosis Clinical Isolates
por: Narayanaswamy, Vidya P., et al.
Publicado: (2019)

Antibacterial Activity of a Natural Clay Mineral against Burkholderia cepacia Complex and Other Bacterial Pathogens Isolated from People with Cystic Fibrosis
por: Behroozian, Shekooh, et al.
Publicado: (2023)

Cysteamine-mediated clearance of antibiotic-resistant pathogens in human cystic fibrosis macrophages
por: Shrestha, Chandra L., et al.
Publicado: (2017)

Swimming Motility in a Longitudinal Collection of Clinical Isolates of Burkholderia cepacia Complex Bacteria from People with Cystic Fibrosis
por: Zlosnik, James E. A., et al.
Publicado: (2014)

Commercial use of Burkholderia cepacia.
por: LiPuma, J J, et al.
Publicado: (1999)

Draft Genome Sequence of Flavobacterium sp. Strain TAB 87, Able To Inhibit the Growth of Cystic Fibrosis Bacterial Pathogens Belonging to the Burkholderia cepacia Complex
por: Presta, Luana, et al.
Publicado: (2016)

Burkholderia cepacia, cystic fibrosis and outcomes following lung transplantation: experiences from a single center in Brazil
por: de Souza Carraro, Danila, et al.
Publicado: (2018)

Identification and molecular epidemiology of nosocomial outbreaks due to Burkholderia cepacia in cystic fibrosis patients of Masih Daneshvary Hospital, Iran
por: SOLTAN DALLAL, M.M., et al.
Publicado: (2014)

Burkholderia Cepacia Endophthalmitis: An Unusual Presentation
por: Deka, Amarendra, et al.
Publicado: (2018)

Emergence of Burkholderia cepacia in ICU Setting
por: Meena, Suneeta, et al.
Publicado: (2019)

Environmental Burkholderia cepacia Complex Isolates from Human Infections
por: Baldwin, Adam, et al.
Publicado: (2007)

Long-Term Colonization of the Cystic Fibrosis Lung by Burkholderia cepacia Complex Bacteria: Epidemiology, Clonal Variation, and Genome-Wide Expression Alterations
por: Coutinho, Carla P., et al.
Publicado: (2011)

Burkholderia cepacia Complex Species Differ in the Frequency of Variation of the Lipopolysaccharide O-Antigen Expression During Cystic Fibrosis Chronic Respiratory Infection
por: Hassan, A. Amir, et al.
Publicado: (2019)

66 Incidence of Burkholderia cepacia complex infection in a Cystic Fibrosis Centre in Buenos Aires City, Argentina, from 2004 to 2014
por: Ibarra, L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i15t7pbmdr9l2tpkqvlq8h4hvo